Horizon Pharma, Inc. (HZNP)

Check out top investors' recommendation for HZNP
Last closing price (N/A)
(0.00%) ? 
Last closing price is the stock price upon last market close (date specified in parenthesis).
Return to date (1m/3m/6m/12m):
N/A ? 
Return to date is the stock return for the specified period of time.
Consensus price target (1m/3m/6m/12m):
18.18
 ? 
Consensus price target is the average analyst price target for a specified period of time.
Buy/Sell Mix (1m/3m/6m/12m):
100%/0%
 ? 
Buy/sell mix the percentage mix between Buy and Sell recommendations for a given company or a research firm. Hold recommendations are excluded.
Description:
Horizon Pharma, Inc., a specialty pharmaceutical company, through its subsidiaries, develops and commercializes medicines for the treatment of arthritis, pain, and inflammatory diseases. The company offers DUEXIS, a proprietary tablet formulation for the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis, and to decrease the risk of developing upper gastrointestinal ulcers in patients who are taking ibuprofen for these indications. It also provides LODOTRA/RAYOS, a proprietary delayed-release formulation of low-dose prednisone for the treatment of moderate to severe active rheumatoid arthritis in adults when accompanied by morning stiffness, as well as approved for the treatment of polymyalgia rheumatica, psoriatic arthritis, ankylosing spondylitis, asthma, chronic obstructive pulmonary disease, and other conditions. The company was founded in 2005 and is headquartered in Deerfield, Illinois.
Sector:
Analyst
An analyst is a professional research analyst or an Investor Wand user who issued a recommendation for a given company.
Research Firm
A Research Firm is a company that researches and rates stocks and publishes recommendations.
Signal
Signal is a recommendation issued by an analyst. Investor Wand considers two types of recommendations: BUY and SELL.
Signal Date
A signal date is a date when a BUY or SELL recommendation was issued for given security.
Initial Price
Initial Price is the first closing price for a specified company upon recommendation release. If the recommendation is issued in after-market hours, the Initial Price is the next day’s closing price (for a given symbol). In case of dividend distributions and stock splits, Initial Price is adjusted.
Price Target
A Price Target is an analyst’s projection of a company’s stock price by the end of the recommendation period. It represents the price at which the analyst would exit his or her existing position.
Closing Date
Closing Date is the expiration date of a recommendation. The validity timeframe of a professional analyst’s recommendation is 12 months. Investor Wand analysts can set their recommendation timeframe to one, three, six, or 12 months.
Return
The return on a single open recommendation is calculated as the maximum of the current return (based on the latest closing price) and the target price return, if the symbol reached the target. The return on a single closed recommendation is calculated as the maximum of the return on the closing date (at the end of recommendation timeframe) and the target price return, if the stock hit the target price. The return is adjusted for one-time events (e.g., stock splits).
Ken Cacciatore Cowen And Company Buy   Nov 10, '17     22.00  Nov 10, '18  N/A 
Louise Chen Guggenheim Securities LLC Buy   Nov 06, '17     17.00  Nov 06, '18  N/A 
Gary Nachman Susquehanna Financial Group Buy   Oct 30, '17     18.00  Oct 30, '18  N/A 
Annabel Samimy Stifel Nicolaus & Company, Inc. Buy   Oct 20, '17     20.00  Oct 20, '18  N/A 
David Amsellem Piper Jaffray Buy   Oct 13, '17     18.00  Oct 13, '18  N/A 
David Steinberg Deutsche Bank Securities Buy   Oct 13, '17     16.00  Oct 13, '18  N/A 
Gary Nachman Susquehanna Financial Group Buy   Sep 26, '17     18.00  Sep 26, '18  N/A 
Annabel Samimy Stifel Nicolaus & Company, Inc. Buy   Sep 15, '17     20.00  Sep 15, '18  N/A 
Michael Yee RBC Capital Markets Buy   Sep 12, '17     16.00  Sep 12, '18  N/A 
Louise Chen Guggenheim Securities LLC Buy   Sep 11, '17     17.00  Sep 11, '18  N/A 
David Amsellem Piper Jaffray Buy   Sep 08, '17     18.00  Sep 08, '18  N/A 
David Steinberg Deutsche Bank Securities Buy   Aug 08, '17     16.00  Aug 08, '18  N/A 
Marc Goodman UBS Buy   Aug 08, '17     16.00  Aug 08, '18  N/A 
Gary Nachman Susquehanna Financial Group Buy   Aug 07, '17     18.00  Aug 07, '18  N/A 
Louise Chen Guggenheim Securities LLC Buy   Jul 30, '17     13.00  Jul 30, '18  N/A 
David Amsellem Piper Jaffray Buy   Jul 14, '17     18.00  Jul 14, '18  N/A 
Annabel Samimy Stifel Nicolaus & Company, Inc. Buy   Jun 27, '17     20.00  Jun 27, '18  N/A 
David Steinberg Deutsche Bank Securities Buy   Nov 02, '16     26.00  Nov 02, '17  N/A 
Charles Duncan Piper Jaffray Buy   Aug 10, '16     33.00  Aug 10, '17  N/A 
David Steinberg Deutsche Bank Securities Buy   Mar 02, '16   17.60  31.00  Mar 02, '17  -8.24% 
< previous123